Habib Yaribeygi

18.8k total citations · 3 hit papers
117 papers, 4.9k citations indexed

About

Habib Yaribeygi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Habib Yaribeygi has authored 117 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Endocrinology, Diabetes and Metabolism, 48 papers in Molecular Biology and 35 papers in Surgery. Recurrent topics in Habib Yaribeygi's work include Diabetes Treatment and Management (41 papers), Pancreatic function and diabetes (25 papers) and Metabolism, Diabetes, and Cancer (22 papers). Habib Yaribeygi is often cited by papers focused on Diabetes Treatment and Management (41 papers), Pancreatic function and diabetes (25 papers) and Metabolism, Diabetes, and Cancer (22 papers). Habib Yaribeygi collaborates with scholars based in Iran, United Kingdom and Qatar. Habib Yaribeygi's co-authors include Amirhossein Sahebkar, Stephen L. Atkin, Alexandra E. Butler, Thozhukat Sathyapalan, Farin Rashid Farokhi, Yunes Panahi, Hedayat Sahraei, Thomas P. Johnston, Tannaz Jamialahmadi and Mina Maleki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Habib Yaribeygi

112 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The impact of stress on body function: a review

2017 707 citations Habib Yaribeygi, Hedayat Sahraei et al. profile →
Insulin resistance: Review of the underlying molecular mechanisms

2018 654 citations Habib Yaribeygi, Farin Rashid Farokhi et al. Journal of Cellular Physiology profile →
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

2020 473 citations Habib Yaribeygi, Thozhukat Sathyapalan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Habib Yaribeygi Iran	33	1.5k	1.5k	817	720	617	117	4.9k
Ernest Adeghate United Arab Emirates	42	1.7k 1.1×	1.7k 1.1×	1.3k 1.5×	1.0k 1.4×	588 1.0×	259	6.1k
Antonio Hernández‐Mijares Spain	38	1.1k 0.7×	1.4k 1.0×	1.1k 1.4×	794 1.1×	772 1.3×	183	4.9k
Berrak Ç. Yeğen Türkiye	46	712 0.5×	1.4k 0.9×	1.3k 1.6×	1.0k 1.4×	759 1.2×	259	7.1k
Jie Zhou China	37	1.8k 1.1×	1.9k 1.2×	797 1.0×	1.5k 2.1×	576 0.9×	135	5.5k
Seung‐Hyun Ko South Korea	45	3.1k 2.0×	1.6k 1.0×	877 1.1×	1.7k 2.4×	820 1.3×	252	6.8k
Abd A. Tahrani United Kingdom	40	2.1k 1.3×	1.0k 0.7×	1.4k 1.7×	1.2k 1.7×	385 0.6×	174	5.2k
Ranganath Muniyappa United States	33	2.0k 1.3×	1.5k 1.0×	1.5k 1.9×	917 1.3×	1.0k 1.7×	85	6.5k
Massimo Fini Italy	40	1.1k 0.7×	1.2k 0.8×	700 0.9×	300 0.4×	622 1.0×	126	5.0k
Giovanni Zuliani Italy	47	956 0.6×	1.4k 0.9×	2.2k 2.7×	1.4k 1.9×	831 1.3×	251	8.1k
Hayder M. Al‐kuraishy Iraq	46	526 0.3×	2.1k 1.4×	1.2k 1.5×	465 0.6×	629 1.0×	369	7.2k

Countries citing papers authored by Habib Yaribeygi

Since Specialization

Citations

This map shows the geographic impact of Habib Yaribeygi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Habib Yaribeygi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Habib Yaribeygi more than expected).

Fields of papers citing papers by Habib Yaribeygi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Habib Yaribeygi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Habib Yaribeygi. The network helps show where Habib Yaribeygi may publish in the future.

Co-authorship network of co-authors of Habib Yaribeygi

This figure shows the co-authorship network connecting the top 25 collaborators of Habib Yaribeygi. A scholar is included among the top collaborators of Habib Yaribeygi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Habib Yaribeygi. Habib Yaribeygi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramezani, Majid, et al.. (2025). Adding empagliflozin to ongoing metformin improves metabolic profile, tg-g and fib-4 indexes and liver function tests in type 2 diabetic patients with NAFLDS, a clinical trial. Expert Review of Endocrinology & Metabolism. 20(6). 633–641.

Yaribeygi, Habib, et al.. (2025). The Emerging role of lipoprotein(a) in diabetic kidney disease: possible pathophysiological links and unresolved mechanisms. Diabetes Research and Clinical Practice. 231. 113040–113040.

Jamialahmadi, Tannaz, et al.. (2025). Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying molecular mechanisms. Neuroscience. 579. 187–197.

Yaribeygi, Habib, et al.. (2024). Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. Current Therapeutic Research. 101. 100764–100764.

Maleki, Mina, Alexandra E. Butler, Tannaz Jamialahmadi, et al.. (2024). Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits. Cellular Signalling. 122. 111335–111335. 1 indexed citations

Yaribeygi, Habib, Mina Maleki, Prashant Kesharwani, et al.. (2024). Exploring the antioxidant properties of semaglutide: A comprehensive review. Journal of Diabetes and its Complications. 38(12). 108906–108906. 5 indexed citations

Yaribeygi, Habib, et al.. (2024). Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits. Heliyon. 10(7). e28837–e28837. 5 indexed citations

Rashidy‐Pour, Ali, et al.. (2023). Saffron and crocin ameliorate prenatal valproic acid-induced autistic-like behaviors and brain oxidative stress in the male offspring rats. Metabolic Brain Disease. 38(7). 2231–2241. 10 indexed citations

Yaribeygi, Habib, et al.. (2023). Nanoparticles with SGLT2 inhibitory activity: Possible benefits and future. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(10). 102869–102869. 2 indexed citations

10.

Yaribeygi, Habib, et al.. (2023). Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitorsin the Diabetic Milieu. Current Medicinal Chemistry. 31(2). 138–151. 5 indexed citations

11.

Ashrafizadeh, Milad, Zahra Ahmadi, Habib Yaribeygi, et al.. (2020). Curcumin Therapeutic Modulation of the Wnt Signaling Pathway. Current Pharmaceutical Biotechnology. 21(11). 1006–1015. 40 indexed citations

12.

Yaribeygi, Habib, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, & Amirhossein Sahebkar. (2020). Obesity and Insulin Resistance: A Review of Molecular Interactions. Current Molecular Medicine. 21(3). 182–193. 17 indexed citations

13.

Yaribeygi, Habib, et al.. (2019). Wingless‐type inducible signaling pathway protein‐1 (WISP1) adipokine and glucose homeostasis. Journal of Cellular Physiology. 234(10). 16966–16970. 12 indexed citations

14.

Yaribeygi, Habib, et al.. (2019). Neuromodulatory effects of anti-diabetes medications: A mechanistic review. Pharmacological Research. 152. 104611–104611. 53 indexed citations

15.

Yaribeygi, Habib, Stephen L. Atkin, Matteo Pirro, & Amirhossein Sahebkar. (2018). A review of the anti‐inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. Journal of Cellular Physiology. 234(6). 8286–8294. 58 indexed citations

16.

Yaribeygi, Habib, Luis E. Simental‐Mendía, Alexandra E. Butler, & Amirhossein Sahebkar. (2018). Protective effects of plant‐derived natural products on renal complications. Journal of Cellular Physiology. 234(8). 12161–12172. 37 indexed citations

17.

Hosseini, Mahboobeh Sadat, et al.. (2018). The effects of plasma levels of vitamin D3 on insulin resistance and biochemical factors of plasma in patients with type 2 diabetes. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Yaribeygi, Habib & Mohammad Taghi Mohammadi. (2017). Protective Effect of Crocin on Kidney Performance in Chronic Uncontrolled Hyperglycemia-Induced Nephropathy in Rat. Journal of Advances in Medical and Biomedical Research. 25(109). 36–49. 11 indexed citations

19.

Yaribeygi, Habib, Hedayat Sahraei, Ali Mohammadi, & Gholam Hossein Meftahi. (2014). Saffron ( Crocus sativus L. ) and morphine dependence: A systematic review article. 2(2). 41. 8 indexed citations

20.

Yaribeygi, Habib, et al.. (2014). Prevalence of cardiovascular risk factors in patients undergoing CABG: brief report. SHILAP Revista de lepidopterología. 72(8). 570–574. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact